1 Cautionary Statements Regarding Forward-looking Statements This presentation is provided by Ping An Healthcare and Technology Company Limited (hereinafter referred to as the "Company"). To the extent any statements made in this report contain information that is not historical, these statements are essentially forward-looking. These forward-looking statements include but are not limited to projections, targets, estimates and business plans that the Company expects or anticipates will or may occur in the f ...

2025 Interim Results Analyst Presentation Where this document refers to the trading of securities through the Shanghai-Hong Kong Stock Connect and/or Shenzhen-Hong Kong Stock Connect (together, the "Stock Connect" programs), the applicable SEHK rules and Hong Kong and Mainland China regulations shall apply. Currently, access to northbound trading is only available to intermediaries licensed or regulated in Hong Kong; southbound trading is only available to intermediaries licensed or regulated in Mainland Ch ...

Financial Performance - Yancoal reported a revenue of $2.68 billion, a 15% decrease compared to $3.138 billion in 1H 2024 [12, 76] - Operating EBITDA was $595 million, with a 23% margin [12] - Profit after tax reached $163 million, resulting in earnings per share of $0.12 [12] - The company holds $1.8 billion in cash with no interest-bearing loans [12] - An interim dividend of $82 million, or $0.0620 per share, was declared at a 50% payout ratio [12] Production and Operations - ROM coal production was 32.2Mt, a 16% increase from 1H 2024 [12, 28] - Saleable coal production reached 24.8Mt, a 15% increase from 1H 2024 [12, 22] - Attributable saleable coal production was 18.9Mt, an 11% increase compared to 1H 2024 [12, 33] - Cash operating costs decreased by 8% to $93/tonne compared to 1H 2024 [12, 37] Safety - The 12-month rolling Total Recordable Injury Frequency Rate (TRIFR) was 6.32, an improvement from 6.73 at the end of 2024, and remains below the industry weighted average of 7.93 [12, 17]

Financial Performance - Group revenue reached RMB 116.0 billion, a 30.5% year-over-year increase[11] - Gross profit margin was 22.5%, up 1.8 percentage points year-over-year[11] - Adjusted net profit reached RMB 10.8 billion, a 75.4% year-over-year increase[11] - Smart EV, AI and other new initiatives revenue reached RMB 21.3 billion, a 233.9% year-over-year increase[11] Smartphone Business - Global smartphone market share ranked top 3 with 14.7%[16] - Mainland China smartphone market share increased 1.0 percentage point year-over-year to 15.3%[16] - Premium smartphone as a percentage of total smartphone units sold in Mainland China increased 5.5 percentage points year-over-year to 27.6%[16] - Global smartphone shipments reached 42.4 million units[38] IoT and Lifestyle Products - IoT and lifestyle products revenue reached RMB 38.7 billion, up 44.7% year-over-year[79] - Smart large home appliances revenue increased 66.2% year-over-year[16] - Global tablet shipments increased 42.3% year-over-year[16] Smart EV and AI Initiatives - Smart EV sales revenue reached RMB 20.6 billion, up 230.3% year-over-year[84] - Xiaomi EV quarterly delivery reached 81,302 vehicles[16] - Locked-in orders for Xiaomi YU7 series reached 240,000 units in 18 hours[16]

2025 INTERIM RESULTS PRESENTATION 2025中期业绩演示材料 AU GU S T 2 0 2 5 2025年8月 1 DISCLAIMER 免责声明 The information contained in this presentation is intended solely for your personal reference. Such information is subject to change without notice and no representation or warranty express or implied is made as to, and no reliance, should be placed on, the fairness, accuracy, completeness or correctness of the information contained in this presentation. This presentation does not intend to provide, and you may not re ...

Tongcheng Travel Holdings Limited Stock Code: 0780 Investor Presentation August 2025 Disclaimer The materials used in this investors presentation are being furnished to you for your information only, which shall be kept in strict confidence. No representation or warranty, express or implied, is made by Tongcheng Travel Holdings Limited (the "Company") or its connected person, or any of their respective directors, officers, employees, advisers or representatives as to, and no reliance should be placed on, th ...

Financial Performance - Group revenue reached RMB 6838 million, a 71% year-over-year increase[3] - Operating profit increased by 91% to RMB 1305 million, with an operating profit margin of 191%[3] - Profit attributable to ordinary equity holders of the company increased by 215% to RMB 914 million[3] - Basic earnings per share increased by 165% to RMB 346 cents[6] Segment Performance - Mass market revenue increased by 45% to RMB 6053 million[3, 11] - Professional sports revenue increased significantly by 325% to RMB 785 million[3, 11] Balance Sheet Highlights - Net cash and cash equivalents increased significantly by 943% to RMB 1913 million[7] - Shareholders' equity increased by 135% to RMB 9876 million[7] Brand Performance & Strategy - Xtep is the No 1 running brand in China, with leading overall wear rate in major marathons[18, 19] - Core Xtep brand revenue increased, with footwear accounting for 584% of revenue[75] - Saucony & Merrell brands experienced revenue growth, with overall revenue increasing by 325%[83] Sustainability - The company recycled approximately 3000 kg of clothes and reduced carbon emissions by over 10000 kg[52, 53]

(327.HK) PAX Global Technology Limited Interim results 2025 Disclaimer The information contained in these presentation materials has been prepared by PAX Global Technology Limited ( "Company" or "PAX") (incorporated in Bermuda with limited liability) solely for use at the presentation to prospective investors for introduction of the Company. By accepting this document, you are agreeing to maintain absolute confidentiality regarding the information disclosed in this document. This document has not been indep ...

(Stock Code: 1177.HK) (RMB bn) 2025 2025 Interim Results Announcement 2025.8.18 Hong Kong CONTENTS Financial Highlights Pipeline Highlights 2 Financial Highlights Both revenue and profit achieved double-digit growth 1.54 3.09 2024 H1 Continuing Operations 2025 H1 Continuing Operations Revenue 15.87 17.57 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributable to owners of the parent (as reported) 1.41 3.39 2024 H1 Continuing Operations 2025 H1 Continuing Operations Profit attributabl ...

Financial Performance - The Group's revenue from continuing operations reached $518.8 million, marking an impressive 81.9% year-over-year increase compared to H1 2024[5,65] - Adjusted net profit from continuing operations soared to $178.0 million, a substantial 509.6% increase compared to the $29.2 million in H1 2024[5,65] - GenScript revenue increased by 11.3% to $247.6 million[65,67] - ProBio experienced significant growth, with revenue reaching $246.9 million, a 511.1% increase[5,65,70] - Bestzyme's revenue grew by 8.4% to $28.3 million[65,73] GenScript Highlights - GenScript served over 42,000 customers in H1 2025, up from 39,000+ in H1 2024[18] - The number of scientific journals citing GenScript increased to over 112,000, compared to 100,000+ in H1 2024[18] - R&D functions account for approximately 10% of the 5700+ employees globally[6] ProBio Highlights - ProBio's cash position is $371.1 million[70] - 20 CDMO projects in H1 2025, with >50% from global customers[42] Bestzyme Highlights - Bestzyme's R&D expenses increased by 62%, from $2.9 million in H1 2024 to $4.7 million in H1 2025[59] - International revenue contribution increased, accounting for 23% of revenue in H1 2025 compared to 21% in H1 2024[73] Guidance - The company revised its revenue growth target for FY 2025 from 10%-15% to 13%-15%[78] - Bestzyme expects 20%-25% revenue growth with Adjusted GPM ~45%[78]